Trial Profile
A Placebo-controlled, Double-blind, Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Japanese Male and Female Subjects and Caucasian Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 3325 (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 20 Jul 2015 New trial record